Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Significant Accounting Policies (Tables)

v3.24.1
Basis of Presentation and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Basis of Presentation and Significant Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Net Loss Per Common Share The following table presents the computation of basic and diluted net loss per common share (in thousands except share and per share amounts):
    Year Ended
December 31,
2023
    Year Ended
December 31,
2022
 
Numerator            
Net loss   $ (28,984 )   $ (14,315 )
Deemed dividend on Series D preferred stock     (6 )    
-
 
Cumulative dividends on Series A preferred stock     (19 )    
-
 
Cumulative dividends on Series B preferred stock     (107 )    
-
 
Cumulative dividends on Series C preferred stock     (30 )    
-
 
Cumulative dividends on Series D preferred stock     (53 )     (55 )
Cumulative dividends on Series F preferred stock     (272 )    
-
 
Cumulative dividends on Series F-1 preferred stock     (110 )    
-
 
Cumulative dividends on Series F-2 preferred stock     (79 )    
-
 
Numerator for basic and diluted net loss per share   $ (29,660 )   $ (14,370 )
                 
Denominator                
Weighted-average common shares outstanding     5,431,201       267,440  
Less: weighted-average shares subject to repurchase     (1,942 )     (1,938 )
Denominator for basic and diluted net loss per share     5,429,259       265,502  
Shares used to compute pro forma net loss per share, basic and diluted                
Net loss per share:                
Basic and diluted
  $ (5.46 )   $ (54.12 )

 

    December 31,  
    2023     2022  
             
Series A preferred stock     3,146       3,146  
Series B preferred stock     33,883       33,883  
Series C preferred stock     9,346       9,346  
Series D preferred stock    
-
      35,278  
Series F preferred stock     501,579      
-
 
Series F-1 preferred stock     72,631      
-
 
Series F-2 preferred stock     124,946      
-
 
Warrants to purchase common stock (excluding penny warrants)     1,715,095       461,066  
Warrants to purchase Series E preferred stock     750,000      
-
 
Options to purchase common stock     382,779       159,295  
Unvested restricted stock units     33,010       10,483  
Commitment shares     200,205      
-
 
      3,826,620       712,497